Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naman Vatsa

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Frontiers in Molecular Neuroscience|December 21, 2018
UBE3A and Its Link With AutismNaman Vatsa, Nihar Ranjan Jana
Frontiers in Molecular Neuroscience|December 19, 2019
Simvastatin Restores HDAC1/2 Activity and Improves Behavioral Deficits in Angelman Syndrome Model MouseVipendra Kumar, Tripti Joshi, Naman Vatsa, et al.
Human Molecular Genetics|October 11, 2017
Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's diseaseBrijesh Kumar Singh, Naman Vatsa, Vipendra Kumar, et al.
Frontiers in Molecular Neuroscience|March 1, 2019
Down-Regulation of miRNA-708 Promotes Aberrant Calcium Signaling by Targeting Neuronatin in a Mouse Model of Angelman SyndromeNaman Vatsa, Vipendra Kumar, Brijesh Kumar Singh, et al.
Human Molecular Genetics|December 24, 2016
Topoisomerase 1 inhibitor topotecan delays the disease progression in a mouse model of Huntington's diseaseShashi Shekhar, Naman Vatsa, Vipendra Kumar, et al.
Molecular Neurobiology|September 2, 2016
Environmental Enrichment Improves Behavioral Abnormalities in a Mouse Model of Angelman SyndromeImran Jamal, Vipendra Kumar, Naman Vatsa, et al.
Neurobiology of Disease|June 4, 2017
Rescue of altered HDAC activity recovers behavioural abnormalities in a mouse model of Angelman syndromeImran Jamal, Vipendra Kumar, Naman Vatsa, et al.
Human Molecular Genetics|July 17, 2014
Deficiency of Ube3a in Huntington's disease mice brain increases aggregate load and accelerates disease pathologyMegha Maheshwari, Shashi Shekhar, Brijesh Kumar Singh, et al.
Molecular Neurobiology|January 3, 2018
Azadiradione Restores Protein Quality Control and Ameliorates the Disease Pathogenesis in a Mouse Model of Huntington's DiseaseBrijesh Kumar Singh, Naman Vatsa, Vinod K Nelson, et al.
Translational Neurodegeneration|June 19, 2025
Pathological α-synuclein elicits granulovacuolar degeneration independent of tauDylan J Dues, Madalynn L Erb, Alysa Kasen, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Molecular Neuroscience|December 21, 2018
UBE3A and Its Link With AutismNaman Vatsa, Nihar Ranjan Jana
Frontiers in Molecular Neuroscience|December 19, 2019
Simvastatin Restores HDAC1/2 Activity and Improves Behavioral Deficits in Angelman Syndrome Model MouseVipendra Kumar, Tripti Joshi, Naman Vatsa, et al.
Human Molecular Genetics|October 11, 2017
Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's diseaseBrijesh Kumar Singh, Naman Vatsa, Vipendra Kumar, et al.
Frontiers in Molecular Neuroscience|March 1, 2019
Down-Regulation of miRNA-708 Promotes Aberrant Calcium Signaling by Targeting Neuronatin in a Mouse Model of Angelman SyndromeNaman Vatsa, Vipendra Kumar, Brijesh Kumar Singh, et al.
Human Molecular Genetics|December 24, 2016
Topoisomerase 1 inhibitor topotecan delays the disease progression in a mouse model of Huntington's diseaseShashi Shekhar, Naman Vatsa, Vipendra Kumar, et al.
Molecular Neurobiology|September 2, 2016
Environmental Enrichment Improves Behavioral Abnormalities in a Mouse Model of Angelman SyndromeImran Jamal, Vipendra Kumar, Naman Vatsa, et al.
Neurobiology of Disease|June 4, 2017
Rescue of altered HDAC activity recovers behavioural abnormalities in a mouse model of Angelman syndromeImran Jamal, Vipendra Kumar, Naman Vatsa, et al.
Human Molecular Genetics|July 17, 2014
Deficiency of Ube3a in Huntington's disease mice brain increases aggregate load and accelerates disease pathologyMegha Maheshwari, Shashi Shekhar, Brijesh Kumar Singh, et al.
Molecular Neurobiology|January 3, 2018
Azadiradione Restores Protein Quality Control and Ameliorates the Disease Pathogenesis in a Mouse Model of Huntington's DiseaseBrijesh Kumar Singh, Naman Vatsa, Vinod K Nelson, et al.
Translational Neurodegeneration|June 19, 2025
Pathological α-synuclein elicits granulovacuolar degeneration independent of tauDylan J Dues, Madalynn L Erb, Alysa Kasen, et al.
Pageof 2